How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

6,129 results for

Depression Screening Tools

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

201. Systematic review of screening tools for depression in persons with epilepsy

Systematic review of screening tools for depression in persons with epilepsy Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect (...) measures Timing and effect measures Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Context and rationale Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Inclusion criteria: Exclusion criteria: Example: Screening will be performed in two phases, namely initial screening based on title and abstract, followed by full-text screening of the eligible

2015 PROSPERO

202. Depression Screening Tools

Depression Screening Tools Depression Screening Tools Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Depression Screening Tools (...) Depression Screening Tools Aka: Depression Screening Tools , Major Depression Evaluation Scales II. Diagnostics: Children (age 7 or older) (CDI) Reynolds Child Depression Scale III. Diagnostics: Adolescents Reynolds Scale CES Depression Scale (CES-D) CES Depression Scale for Children (BDI) IV. Diagnostics: Adults ( ) (BDI) II PC (BDI-PC) CES Depression Scale (CES-D) V. Diagnostics: Elderly (BDI) CES Depression Scale (CES-D) (GDS, also in short version) VI. Diagnostics: Postpartum Depression VII

2015 FP Notebook

203. Depression screening via a smartphone app: cross-country user characteristics and feasibility. Full Text available with Trip Pro

the PHQ-9 questionnaire more than once.Smartphone apps can be used to deliver a screening tool for depression across a large number of countries. Apps have the potential to play a significant role in disease screening, self-management, monitoring, and health education, particularly among younger adults.© The Author 2014. Published by Oxford University Press on behalf of the American Medical Informatics Association. All rights reserved. For Permissions, please email: journals.permissions@oup.comFor (...) Depression screening via a smartphone app: cross-country user characteristics and feasibility. Smartphone applications (apps) have the potential to be valuable self-help interventions for depression screening. However, information about their feasibility and effectiveness and the characteristics of app users is limited. The aim of this study is to explore the uptake, utilization, and characteristics of voluntary users of an app for depression screening.This was a cross-sectional study of a free

2015 Journal of the American Medical Informatics Association

204. Committee opinion no. 630: screening for perinatal depression. (Abstract)

on women, infants, and families. Several screening instruments have been validated for use during pregnancy and the postpartum period. Although definitive evidence of benefit is limited, the American College of Obstetricians and Gynecologists recommends that clinicians screen patients at least once during the perinatal period for depression and anxiety symptoms using a standardized, validated tool. Although screening is important for detecting perinatal depression, screening by itself is insufficient (...) Committee opinion no. 630: screening for perinatal depression. Perinatal depression, which includes major and minor depressive episodes that occur during pregnancy or in the first 12 months after delivery, is one of the most common medical complications during pregnancy and the postpartum period, affecting one in seven women. It is important to identify pregnant and postpartum women with depression because untreated perinatal depression and other mood disorders can have devastating effects

2015 Obstetrics and Gynecology

205. Depression screening and referral in cardiac wards: A 12-month patient trajectory. (Abstract)

of wellbeing ( F(1,186)=42.47, p<0.001) and social support ( F(1,177)=25.40, p<0.0001), compared to those at 'no to low' risk of depression. Levels of depression and wellbeing remained fairly constant over the 12-month trajectory. Surgical and medical treatment groups were of similar psychological composition over the 12-month period.These findings attest to the effectiveness and predictive validity of a simple nurse-administered screening tool designed to identify depression in hospital patients with CHD (...) Depression screening and referral in cardiac wards: A 12-month patient trajectory. Depression is common among patients with coronary heart disease (CHD) and has a major impact on their quality of life, morbidity and mortality.The aim of this study was to map the 12-month psychosocial outcomes of patients with CHD who were screened positive for depression in an acute cardiac ward.A prospective cohort study was conducted of the psychosocial trajectory (depression, anxiety, wellbeing, social

2015 European Journal of Cardiovascular Nursing

206. The validity of the Patient Health Questionnaire for screening depression in chronic care patients in primary health care in South Africa. Full Text available with Trip Pro

The validity of the Patient Health Questionnaire for screening depression in chronic care patients in primary health care in South Africa. People with chronic health conditions are known to have a higher prevalence of depressive disorder. The Patient Health Questionnaire (PHQ-9) is a widely-used screening tool for depression which has not yet been validated for use on chronic care patients in South Africa.A sample of 676 chronic care patients attending two primary health facilities in North (...) curve (AUROC) of 0.85 (95 % CI 0.82-0.88), which was higher than the AURUC for the PHQ-2 (0.76, 95 % CI 0.73-0.79). Using a cut-point of 9, the PHQ-9 has sensitivity of 51 % and specificity of 94 %. The PHQ-9 AUROC for the sub-samples of patients with HIV and with hypertension were comparable (0.85 and 0.86, respectively).The PHQ-9 is useful as a screening tool for depression among patients receiving treatment for chronic care in a public health facility.

2015 BMC Psychiatry

207. Depression, anxiety, pain and quality of life in people living with chronic hepatitis C: a systematic review and meta-analysis

of electronic databases and websites was undertaken. Screening, quality assessment and data extraction were conducted using specialist software. The key criterion for inclusion in a synthesis was a study’s testing of the association between HCV and either quality of life or conditions specified as important by advocacy groups: depression, anxiety or painful conditions. Other criteria relating to study populations, measures and matching of study groups were also applied. Two reviewers assessed included (...) Depression, anxiety, pain and quality of life in people living with chronic hepatitis C: a systematic review and meta-analysis Depression, anxiety, pain and quality of life in people living with chronic hepatitis C A systematic review and meta-analysis Ginny Brunton, Jenny Caird, Katy Sutcliffe, Rebecca Rees, Gillian Stokes, Sandy Oliver, Claire Stansfield, Alexis Llewellyn, Mark Simmonds, James Thomas EPPI-Centre Social Science Research Unit UCL Institute of Education University College London

2015 EPPI Centre

208. The Spanish version of the Fibromyalgia Rapid Screening Tool: translation, validity and reliability Full Text available with Trip Pro

international standards. Internal consistency and temporal stability were assessed. The ability of the FiRST global score as a screening tool for fibromyalgia (criterion validity) was assessed by logistic regression analysis. To determine the degree to which potential confounders might affect the criterion validity of the FiRST (divergent validity), it was reassessed by hierarchical multivariate logistic regression, entering demographics in a first step, followed by pain, anxiety and depression (...) of the FiRST may be used as a screening tool for fibromyalgia even in those patients whose cognitive style is characterized by catastrophizing about pain and high levels of functional disability, anxiety and depression. The clinical consequences of the moderate specificity shown by this Spanish version of the FiRST are discussed.

2014 EvidenceUpdates

209. Psychopathological Features of Bipolar Depression: Italian Validation of the Bipolar Depression Rating Scale (I-BDRS) Full Text available with Trip Pro

< 0.001; YMRS r = 0.46 p < 0.0001). The mixed state sub-scale shows usefulness in differentiating bipolar from unipolar patients. I-BDRS could be a sensitive tool, both in pure depression and in mixed states, and could be used in the everyday screening and treatment of Bipolar Disorder. (...) Psychopathological Features of Bipolar Depression: Italian Validation of the Bipolar Depression Rating Scale (I-BDRS) Background: Aim of the study was the validation of the Bipolar Disorder Rating Scale (BDRS) in an Italian population. Secondary aim was the evaluation of differences between unipolar and bipolar depression and between bipolar I and II depressed patients. Method: 125 Bipolar Disorder and 60 Major Depressive Disorder patients were administered an Italian translation of the BDRS (I

2018 Frontiers in psychology

210. Recommendations on screening for cognitive impairment in older adults

., cut-off) used to define mild cognitive impairment, age at the initial assessment and length of follow-up. 5 Published Canadian cohort prevalence rates for mild cognitive impairment are not available. Studies from the United States have reported prevalence ranging from 9.9% to 35.2% among adults aged 70 or older. 6–8 Cognitive impairment is commonly assessed using screening tools such as the Mini-Mental State Examination (MMSE), the Montreal Cogni- tive Assessment (MoCA) and the cognitive sub (...) ) produce only small benefits, which do not appear to be clinically significant. • Existing studies suggest that about 1 in 10 people without cognitive impairment may erroneously screen positive for mild cognitive impairment using the Mini-Mental State Examination and that 1 in 4 people may incorrectly be classified as positive using the Montreal Cognitive Assessment tool. • The task force recommendation against screening asymptomatic adults 65 years of age and older for cognitive impairment is based

2015 CPG Infobase

211. Development of a prenatal psychosocial screening tool for post-partum depression and anxiety. Full Text available with Trip Pro

Development of a prenatal psychosocial screening tool for post-partum depression and anxiety. Post-partum depression (PPD) is the most common complication of pregnancy in developed countries, affecting 10-15% of new mothers. There has been a shift in thinking less in terms of PPD per se to a broader consideration of poor mental health, including anxiety after giving birth. Some risk factors for poor mental health in the post-partum period can be identified prenatally; however prenatal screening (...) tools developed to date have had poor sensitivity and specificity. The objective of this study was to develop a screening tool that identifies women at risk of distress, operationalized by elevated symptoms of depression and anxiety in the post-partum period using information collected in the prenatal period.Using data from the All Our Babies Study, a prospective cohort study of pregnant women living in Calgary, Alberta (N = 1578), we developed an integer score-based prediction rule

2012 Paediatric and perinatal epidemiology

212. Validity of the Beck Depression Inventory as a Screening Tool for a Clinical Mood Disorder in Bariatric Surgery Candidates. (Abstract)

Validity of the Beck Depression Inventory as a Screening Tool for a Clinical Mood Disorder in Bariatric Surgery Candidates. The Beck Depression Inventory (BDI) is one of the most commonly used instruments to assess depression in persons with obesity. While it has been validated in normal and psychiatric populations, in obese populations, its validity remains uncertain. This study aimed to investigate the validity and reliability of the BDI-IA and BDI-II in severely obese bariatric surgery (...) (26.9 %) met the criteria for a mood disorder, with 37 meeting the criteria for current major depressive disorder. Individuals diagnosed with a clinical mood disorder had significantly higher scores on the BDI (BDI-IA, 23.59 ± 9.69 vs. 12.76 ± 8.29; BDI-II, 22.93 ± 5.22 vs. 11.25 ± 8.44). Our results indicated that, as a screening tool for a clinical mood disorder, the BDI-II had an optimal cutoff of 13, with a sensitivity of 100 and specificity of 67.75.Results indicated that the BDI-IA should

2012 Obesity Surgery

213. Hepatitis C Screening

• Hepatitis B surface antibody • CBC/PLT/DIFF • HIV • AST • ALT • Alkaline phosphatase • Total bilirubin • Direct bilirubin • Albumin • Ferritin • Iron and TIBC • Creatinine with GFR • Protime/INR • APRI score Additionally, the Epic referral asks about screening for alcohol use and depression with the AUDIT-C and PHQ-2 questionnaires. Results of these screens should prompt the referring provider to initiate treatment for depression and substance abuse. The SmartPhrases .AVSHEPCNEWDIAGNOSIS (...) Hepatitis C Screening © 2015 Kaiser Foundation Health Plan of Washington. All rights reserved. 1 Hepatitis C Screening Guideline Major Changes as of September 2016 2 Background 2 Screening 3 Referrals for Staging and Treatment 4 Treatment and Surveillance Recommendations 5 Evidence Summary/References 6 Guideline Development Process and Team 7 Last guideline approval: September 2016 Guidelines are systematically developed statements to assist patients and providers in choosing appropriate health

2016 Kaiser Permanente Clinical Guidelines

214. N1-benzenesulfonyl-2-pyrazoline hybrids in neurological disorders: Syntheses, biological screening and computational studies Full Text available with Trip Pro

N1-benzenesulfonyl-2-pyrazoline hybrids in neurological disorders: Syntheses, biological screening and computational studies A novel series of 1,3,5-trisubstituted-2-pyrazolines (5a-5t) was prepared via Claisen Schmidt condensation, followed by heterocyclization with hydrazine hydrate, substitution of N1 hydrogen of 2-pyrazoline nucleus with 4-chlorobenzenesulfonylchloride, applying conventional and green chemistry approaches. Among the two, microwave assisted organic synthesis (MAOS) emerged (...) as a better synthetic tool in terms of faster reaction rate and high yield. Various physicochemical and spectral studies were conducted to characterize the synthesized derivatives including- IR, Mass, 1H-NMR, 13C-NMR and elemental analysis. During pharmacological evaluation, compound 5b showed excellent anti-anxiety activity and compound 5k exhibited the best antidepressant effect at the tested doses, 50 and 100 mg/kg b.w., being comparable to diazepam and imipramine, respectively. The docking experiments

2018 EXCLI journal

215. Validation of the Refugee Health Screener-15 for the assessment of perinatal depression among Karen and Burmese women on the Thai-Myanmar border. Full Text available with Trip Pro

women-particularly those living in low- and middle-income regions-remains challenging, partly due to the lack of locally-validated and culturally appropriate screens tools. This study formally validates Burmese and Sgaw Karen versions of the Refugee Health Screener-15 (RHS-15) as a screening tool for perinatal depression among migrant women living on the Thai-Myanmar border. The Structured Clinical Interview for the Diagnosis of DSM-IV Disorders (SCID) was used as the gold-standard comparator (...) Validation of the Refugee Health Screener-15 for the assessment of perinatal depression among Karen and Burmese women on the Thai-Myanmar border. Perinatal depression is common, and left untreated can have significant and long-lasting consequences for women, their children and their families. Migrant women are at particular risk of perinatal depression as a result of a multitude of stressors experienced before, during and after migration. Identification of perinatal depression among migrant

2018 PLoS ONE

216. Poststroke Depression: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

not require treatment for depression. Screening is useful for prevalent conditions that can be effectively treated but not readily detected without screening. Three key factors are important to consider when determining whether screening is useful for PSD: (1) the validity and reliability of screening tools to detect PSD; (2) whether treatment of PSD improves depressive symptoms, QOL, functional outcomes, and mortality; and (3) whether PSD screening improves outcomes. In this section, we address the first (...) and mortality requires a rigorous analysis of the interactions with other key variables such as depression, disability, and comorbid medical conditions. In summary, PSD is associated with higher mortality after stroke. Screening for PSD Stroke patients present unique challenges to identifying depression. Stroke-related neurological symptoms such as aprosodic speech, abulia, or flat affect may hinder healthcare practitioners’ identification of PSD, whereas aphasia may lead to undiagnosed and inadequate

2016 American Heart Association

217. The impact of measurement differences on cross-country depression prevalence estimates: A latent transition analysis. Full Text available with Trip Pro

-invariance in the way standard tools measure depression across countries. This paper attempts to discern the extent to which measurement differences are responsible for reported differences in the prevalence of depression across countries.This analysis uses data from the World Mental Health Surveys, a coordinated series of psychiatric epidemiology studies in 27 countries using multistage household probability samples to assess prevalence and correlates of mental disorders. Data in the current study (...) categories based on the variation in their responses to questions in each of three sequential parts of the CIDI depression module: 1) The initial screening items, 2) Additional duration and severity exclusion criteria, and 3) The core symptom questions. After each of these parts, exclusion criteria expel respondents from the remainder of the diagnostic interview, rendering a diagnosis of "not depressed". Latent class models were fit to each of the three parts in each of the four countries, and model fit

2018 PLoS ONE

218. Depression

activities that may have a high potential for adverse consequences. 4 UMHS Depression Guideline Update, August 2011 Table 3. Screening for Depression A quick way of screening patients for depression is to ask patients these two questions: Over the past two weeks, have you often been bothered by: Not at all (0) Several days (1) More than half the days (2) Nearly every day (3) 1. Little interest or pleasure in doing things? 2. Feeling down, depressed, or hopeless? The total score is tallied (...) a prior personal or family history of depression. On further questioning they will often admit to having a relative who was ‘moody’ or had to ‘take a rest’ for several weeks. They may relate having to drop out of school for a time because of difficulty coping. It is important to screen for bipolar disorder in any patient presenting with depression. Traditional teaching has suggested that as many as 30-50% of patients with underlying bipolar disorder will develop acute mania when started

2016 University of Michigan Health System

219. Nonpharmacologic Versus Pharmacologic Treatment of Adult Patients With Major Depressive Disorder: A Clinical Practice Guideline From the American College of Physicians Full Text available with Trip Pro

of depressive symptoms during the maintenance phase and is considered a new, distinct episode. Response to treatment (typically defined as ≥50% reduction in measured severity) can be quantified using various tools, such as the Patient Health Questionnaire-9 (PHQ-9) ( ) or the Hamilton Depression Rating Scale (HAM-D) ( ). Figure 1. Phases of treatment of major depression. Adapted from reference . T X = treatment. Various treatment approaches can be used to manage MDD, such as psychotherapy, complementary (...) , insomnia, low energy, or somatization) or demographic characteristics (age, sex, race, or ethnicity)? The Clinical Guidelines Committee was particularly interested in comparative effectiveness of treatment according to MDD severity (key questions 1b, 2b, and 3b) because depression screening is becoming more widespread, which will tend to increase the proportion of patients being diagnosed with milder MDD. Search Strategy Reviewers searched MEDLINE (via PubMed), EMBASE, the Cochrane Library, AMED

2016 American College of Physicians

220. Delirium, Dementia, and Depression in Older Adults: Assessment and Care, Second Edition

, Second Edition PRACTICE RECOMMENDATIONS LEVEL OF EVIDENCE RECOMMENDATIONS RELATED TO DEPRESSION 10.0 Assessment Recommendation 10 .1: Assess for depression during assessments and ongoing observations when risk factors or signs and symptoms of depression are present . Use validated, context- specific screening or assessment tools, and collaborate with the older adult, his/ her family/care partners, and the interprofessional team . Ia & V Recommendation 10 .2: Assess for risk of suicide when depression (...) Recommendation 15 .1: Organizations demonstrate leadership and maintain a commitment to foundational principles that support care for older adults with delirium, dementia, and depression, including: ? person- and family-centred care (level of evidence = Ia), ? collaborative, interprofessional care (level of evidence = Ia), and ? healthy work environments (level of evidence = V) . Ia & V Recommendation 15 .2: Organizations select validated screening and assessment tools for delirium, dementia, and depression

2016 Registered Nurses' Association of Ontario

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>